Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades.
about
The pathogenicity of the Streptococcus genusClinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistancePopulation-based epidemiology and microbiology of community-onset bloodstream infectionsEpidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factorsStreptococcus pneumoniae serotype-2 childhood meningitis in Bangladesh: a newly recognized pneumococcal infection threatUsing pneumococcal carriage data to monitor postvaccination changes in invasive disease.Periodic cycles of pneumococcal serotypes carried by children before and after 7-valent pneumococcal conjugate vaccine.Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, KenyaEffect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.Invasive pneumococcal isolates from Danish infants (0 - 90 Days) during the years 1943 to 2013Serotype replacement in disease after pneumococcal vaccinationVaccine herd effect.Population snapshot of Streptococcus pneumoniae causing invasive disease in South Africa prior to introduction of pneumococcal conjugate vaccines.Effect of pneumococcal conjugate vaccination in Uruguay, a middle-income country.Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008Serotype distribution in non-bacteremic pneumococcal pneumonia: association with disease severity and implications for pneumococcal conjugate vaccinesEpidemiology and population structure of serotypes 1, 5 and 7f carried by children in Portugal from 1996-2010 before introduction of the 10-valent and 13-valent pneumococcal conjugate vaccines.The majority of adult pneumococcal invasive infections in Portugal are still potentially vaccine preventable in spite of significant declines of serotypes 1 and 5.Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.Invasive pneumococcal infections in Vellore, India: clinical characteristics and distribution of serotypes.Population genetic structure of Streptococcus pneumoniae in Kilifi, Kenya, prior to the introduction of pneumococcal conjugate vaccine.Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations.Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes.A Pneumococcal Carriage Study in Danish Pre-school Children before the Introduction of Pneumococcal Conjugate Vaccination.Simultaneous identification of 29 prevalent invasive pneumococcal serotypes or pairs of serotypes by hybridization-ligation PCR.Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the NetherlandsImpact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis.Whole Genome Sequencing of 39 Invasive Streptococcus pneumoniae Sequence Type 199 Isolates Revealed Switches from Serotype 19A to 15BGenetic Variation in NFKBIE Is Associated With Increased Risk of Pneumococcal Meningitis in Children.Insight Into Resistance Phenotypes of Emergent Non 13-valent Pneumococcal Conjugate Vaccine Type Pneumococci Isolated From Invasive Disease After 13-valent Pneumococcal Conjugate Vaccine Implementation in France.Molecular surveillance of nasopharyngeal carriage of Streptococcus pneumoniae in children vaccinated with conjugated polysaccharide pneumococcal vaccinesSerotype Distribution and Antimicrobial Susceptibilities of Invasive Streptococcus pneumoniae Isolates from Adults in Korea from 1997 to 2012Prevnar 7 Childhood Immunization Program and Serotype Replacement: Changes in Pneumococcal Incidence and Resulting Impact on Health Care Costs in Alberta (2003-2008).Relating Pneumococcal Carriage Among Children to Disease Rates Among Adults Before and After the Introduction of Conjugate VaccinesSerotypes and Antibiotic Susceptibility of Streptococcus pneumoniae Isolates from Invasive Pneumococcal Disease and Asymptomatic Carriage in a Pre-vaccination Period, in Algeria.Serotype-specific effect of influenza on adult invasive pneumococcal pneumonia.Forecasting Trends in Invasive Pneumococcal Disease among Elderly Adults in Quebec.Region-specific diversification of the highly virulent serotype 1 Streptococcus pneumoniae.Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015.Global prevailing and emerging pediatric pneumococcal serotypes.
P2860
Q24600416-52BA0F0F-E8E8-48DC-9AB6-300D9B6C3BC7Q26851961-DD6D68AE-688E-4C52-B88C-E01BBD8007FFQ27013639-0A65F5EB-5898-4078-BC6A-ED9C42A8E839Q27685556-01DE368B-5FA2-49B5-9DC1-76B10A98776AQ28730839-94651449-605B-4041-97EB-00BB50384754Q30665494-643626CE-E318-4500-8820-B83AE60574C2Q33614566-09454FFB-BE25-46ED-B576-D5FE2ECF7065Q33776584-9A1F756C-8225-4B85-A887-884377F0E3D9Q33869370-8669BD34-1DE4-4586-88AD-3DE07C72A0B6Q34090191-29DBC2FB-39CF-43E2-80AD-28504CD710F2Q34178363-7CEDB836-2F7C-4A73-83C6-3F7CC9F0BAF1Q34186752-757C736E-AF56-4896-B4A0-5253721F5308Q34215103-651160D6-CD34-44DA-A3E5-F9218481FD16Q34466269-9EE2245A-9C22-441F-9AA0-26A060614E66Q34933012-66700186-25C1-46CA-BC9D-5A6E6D28B0A9Q34979620-5A956ED3-A7A4-41F8-BF41-104B8C67476DQ34995088-C6B11E41-700D-4D5C-85F2-9B5AB42EA129Q34997063-86A851C6-1FDB-4B57-8226-38DD41CFCDB9Q35004396-9D44670C-3D9E-484E-A11D-991FC849F585Q35037317-F31C92D3-2822-4B64-9A4B-720BE75EE6B1Q35055346-D5013933-5E3E-4376-8D78-B3BFDD082A86Q35124898-2A9A7F8F-D1FC-4B43-9C9C-64A077CF7B17Q35927343-AED1403C-6817-49D8-A007-FBA6662FC32DQ35969430-361FA857-B62F-4AA0-88D3-EBF3652E111AQ36022999-36B689E6-5916-474F-A51A-2F1E24ABE142Q36039569-B9075E1B-B7D5-4CFE-ADF7-3A9A9B83F6ADQ36229752-665A8F33-E2C8-4013-8558-129D9F0E969AQ36238637-410029B8-8858-4EA5-A08C-7F659171AB59Q36538750-8567B3A7-4497-4969-8A54-22F9DD0ECE65Q36650547-14CF820F-1C02-4971-A394-D82C5CD6F4AEQ36764806-E259C141-4DF7-47EA-B073-7306A86F5675Q36809649-01EC174F-FA6D-4B79-9946-BDDF543E0A59Q36942824-2AEA8588-693F-4D87-90BB-38625466747AQ36952719-48B30B1F-10A6-435A-907B-65CA319B0689Q36999700-B25D7DFD-62E1-4C57-90FC-C9C8438DDA22Q37464089-257FA562-B46E-440C-9522-58FB6F562040Q37633201-B76A55DC-93A2-4C7D-924F-4CF8B231774DQ37658047-7EEAF337-3763-4555-8D93-6B383AE04915Q37708522-58AA809E-17F2-494A-AF7A-9FF64E78F023Q37821484-DF35A16B-841F-4F7F-9D57-3EFE400506FB
P2860
Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Temporal trends in invasive pn ...... ccal serotypes over 7 decades.
@en
Temporal trends in invasive pn ...... ccal serotypes over 7 decades.
@nl
type
label
Temporal trends in invasive pn ...... ccal serotypes over 7 decades.
@en
Temporal trends in invasive pn ...... ccal serotypes over 7 decades.
@nl
prefLabel
Temporal trends in invasive pn ...... ccal serotypes over 7 decades.
@en
Temporal trends in invasive pn ...... ccal serotypes over 7 decades.
@nl
P2093
P50
P356
P1476
Temporal trends in invasive pn ...... ccal serotypes over 7 decades.
@en
P2093
Helle B Konradsen
Jens Jørgen Christensen
Margit Kaltoft
Palle Valentiner-Branth
Thomas Hjuler
Zitta B Harboe
P304
P356
10.1086/649872
P407
P50
P577
2010-02-01T00:00:00Z